Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick

    Editors Pick - Page 19

    Health Ministry, WHO join hands to redesignate NHSRC for development of medical devices

    Health Ministry, WHO join hands to redesignate NHSRC for development of medical devices

    Farhat Nasim4 Oct 2019 5:06 PM IST
    This year in collaboration with WHO's country office, NHSRC developed a guidance document for the health ministry's free diagnostics initiative to...
    Zydus announces positive results from EVIDENCES IV Phase 2 clinical trial of Saroglitazar Magnesium in NAFLD and NASH

    Zydus announces positive results from EVIDENCES IV Phase 2 clinical trial of Saroglitazar Magnesium in NAFLD and NASH

    Medical Dialogues Bureau3 Oct 2019 4:35 PM IST
    Zydus Cadila recently announced that Saroglitazar Magnesium has achieved the primary end-points in the EVIDENCES IV trial in patients with NAFLD and...
    Sub-committee to align Drugs And Cosmetics, Magical Remedies Act to regulate Medical Advertisements: CDSCO Committee

    Sub-committee to align Drugs And Cosmetics, Magical Remedies Act to regulate Medical Advertisements: CDSCO Committee

    Farhat Nasim2 Oct 2019 11:48 AM IST
    New Delhi: The Drug Consultative Committee (DCC), functional under the apex drug regulatory body, Central Drug Standard Control Organisation (CDSCO)...
    Pharmacokinetic study of Avastin: Cadila to submit revised protocol to CDSCO committee

    Pharmacokinetic study of Avastin: Cadila to submit revised protocol to CDSCO committee

    Farhat Nasim1 Oct 2019 4:09 PM IST
    New Delhi: The apex drug regulatory body, Central Drug Standard Control Organisation's (CDSCO) Subject Expert Committee (SEC) recently recommended...
    PIL against Health Ministry notifying 8 medical devices as DRUGS, Delhi HC seeks Centre reply

    PIL against Health Ministry notifying 8 medical devices as DRUGS, Delhi HC seeks Centre reply

    Medical Dialogues Bureau30 Sept 2019 5:54 PM IST
    It was submitted that notifying blood monitoring devices, digital thermometers, nebulizers and glucometers as DRUGS will result in a substantial hike...
    Health Ministry reprimands CDSCO officers for frequent visit to ministry office

    Health Ministry reprimands CDSCO officers for frequent visit to ministry office

    Farhat Nasim29 Sept 2019 12:30 PM IST
    All CDSCO officers have been accordingly advised by the Health Ministry via the circular to be careful and not to visit the Ministry except on being...
    A Vaidheesh re-elected President of OPPI for the third consecutive year

    A Vaidheesh re-elected President of OPPI for the third consecutive year

    Medical Dialogues Bureau28 Sept 2019 10:26 AM IST
    A. Vaidheesh, Vice President, South Asia & Managing Director, GlaxoSmithKline Pharmaceuticals Ltd. has been re-elected as the President for OPPI,...
    CDSCO commitee warns against repacking of Active Pharmaceutical Ingredients into smaller packs by Wholesalers

    CDSCO commitee warns against repacking of Active Pharmaceutical Ingredients into smaller packs by Wholesalers

    Meghna A Singhania27 Sept 2019 12:19 PM IST
    New Delhi : Taking into consideration, the proposal on measures need to be taken to address the issue of repacking of Active Pharmaceutical...
    Biocon subsidiary acquires Chennai-based biological research facility from Pfizer Healthcare

    Biocon subsidiary acquires Chennai-based biological research facility from Pfizer Healthcare

    Medical Dialogues Bureau26 Sept 2019 2:08 PM IST
    Biotechnology major Biocon on Tuesday said its subsidiary has acquired a Chennai-based biological research facility from Pfizer Healthcare for an...
    CDSCO warns against Cancer Causing Impurities in anti-acidity drug Ranitidine, writes to state drug controllers

    CDSCO warns against Cancer Causing Impurities in anti-acidity drug Ranitidine, writes to state drug controllers

    Farhat Nasim25 Sept 2019 1:19 PM IST
    New Delhi: To ensure patient safety, the country's apex drug regulatory body, Central Drugs Standard Control Organisation (CDSCO) has ordered an...
    SEBI slaps fine of Rs 22 crore on Aurobindo Pharma, promoters for insider trading

    SEBI slaps fine of Rs 22 crore on Aurobindo Pharma, promoters for insider trading

    Farhat Nasim24 Sept 2019 12:00 PM IST
    The probe found that the promoter entities traded in the scrip of APL based on unpublished price sensitive information or UPSI pertaining to Aurobindo...
    Make drugmakers upload data in SUGAM portal: CDSCO Committee recommends State Drug Authorities

    Make drugmakers upload data in SUGAM portal: CDSCO Committee recommends State Drug Authorities

    Farhat Nasim23 Sept 2019 5:46 PM IST
    New Delhi: The Drugs Consultative Committee (DCC), functional under Central Drugs Standard Control Organisation (CDSCO), recently recommended the...
    PrevNext

    Popular Stories

    Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by manufacturers

    Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by...

    NPPA fixes prices of 29 formulations under DPCO, check out details

    NPPA fixes prices of 29 formulations under DPCO, check out details

    Metropolis Healthcare Q2 profit up 44 pc to Rs 43 crore

    Metropolis Healthcare Q2 profit up 44 pc to Rs 43 crore

    Lupin gets USFDA EIR for Nagpur Facility

    Lupin gets USFDA EIR for Nagpur Facility

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok